Entegris, Inc. (ENTG) Stock Forecast
Data as of Jun 16, 2026Technology · Current price $155.05 (-4.91%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 11, 2026 | Aleksey Yefremov | KeyBanc | $156.00 | +0.6% |
| Jan 15, 2026 | Timothy Arcuri | UBS | $145.00 | -6.5% |
| Jan 9, 2026 | Aleksey Yefremov | KeyBanc | $111.00 | -28.4% |
| Sep 4, 2025 | Edward Yang | Oppenheimer | $95.00 | -38.7% |
| Jul 31, 2025 | Aleksey Yefremov | KeyBanc | $103.00 | -33.6% |
| Nov 5, 2024 | Bhavesh Lodaya | BMO Capital | $135.00 | -12.9% |
| Nov 5, 2024 | Charles Shi | Needham | $120.00 | -22.6% |
| Nov 5, 2024 | Aleksey Yefremov | KeyBanc | $154.00 | -0.7% |
| Sep 16, 2024 | Atif Malik | Citigroup | $130.00 | -16.2% |
| Aug 23, 2024 | David Silver | C.L. King | $150.00 | -3.3% |
| Aug 1, 2024 | Bhavesh Lodaya | BMO Capital | $145.00 | -6.5% |
| Aug 1, 2024 | John Roberts | Mizuho Securities | $143.00 | -7.8% |
| Jul 31, 2024 | Michael Harrison | Seaport Global | $150.00 | -3.3% |
| Jun 20, 2024 | Melissa Weathers | Deutsche Bank | $160.00 | +3.2% |
| May 28, 2024 | Charles Shi | Needham | $150.00 | -3.3% |
| Feb 15, 2024 | Christian Schwab | Craig-Hallum | $150.00 | -3.3% |
| Jun 20, 2023 | Bhavesh Lodaya | Loop Capital Markets | $129.00 | -16.8% |
| Sep 23, 2022 | Christian Schwab | Craig-Hallum | $120.00 | -22.6% |
| Aug 15, 2022 | Kieran de Brun | Mizuho Securities | $148.00 | -4.5% |
| Dec 1, 2021 | Patrick Ho | Stifel Nicolaus | $180.00 | +16.1% |
Top Analysts Covering ENTG
ENTG vs Sector & Market
| Metric | ENTG | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.29 | 2.35 | 2.41 |
| Analyst Count | 14 | 14 | 19 |
| Target Upside | +2.0% | +1281.8% | +17.1% |
| P/E Ratio | 93.79 | 38.36 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.42B | $3.43B | $3.44B | 8 |
| 2027-03-31 | $894M | $902M | $912M | 3 |
| 2027-06-30 | $928M | $936M | $946M | 3 |
| 2027-09-30 | $961M | $970M | $980M | 3 |
| 2027-12-31 | $986M | $995M | $1.01B | 3 |
| 2028-03-31 | $972M | $980M | $991M | 2 |
| 2028-06-30 | $1.00B | $1.01B | $1.02B | 2 |
| 2028-09-30 | $1.04B | $1.05B | $1.06B | 2 |
| 2028-12-31 | $1.06B | $1.07B | $1.09B | 2 |
| 2029-12-31 | $3.84B | $3.95B | $4.03B | 2 |
| 2030-12-31 | $4.17B | $4.30B | $4.38B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.29 | $3.41 | $3.42 | 6 |
| 2027-03-31 | $0.97 | $0.98 | $0.99 | 2 |
| 2027-06-30 | $1.06 | $1.07 | $1.08 | 2 |
| 2027-09-30 | $1.17 | $1.19 | $1.20 | 2 |
| 2027-12-31 | $1.27 | $1.28 | $1.30 | 2 |
| 2028-03-31 | $1.36 | $1.37 | $1.39 | 3 |
| 2028-06-30 | $1.42 | $1.43 | $1.45 | 3 |
| 2028-09-30 | $1.49 | $1.50 | $1.52 | 3 |
| 2028-12-31 | $1.51 | $1.53 | $1.55 | 3 |
| 2029-12-31 | $4.68 | $4.86 | $4.99 | 1 |
| 2030-12-31 | $5.54 | $5.75 | $5.90 | 1 |
Frequently Asked Questions
What is the analyst consensus for ENTG?
The consensus among 14 analysts covering Entegris, Inc. (ENTG) is Buy with an average price target of $134.00.
What is the highest price target for ENTG?
The highest price target for ENTG is $180.00, set by Patrick Ho at Stifel Nicolaus on 2021-12-01.
What is the lowest price target for ENTG?
The lowest price target for ENTG is $95.00, set by Edward Yang at Oppenheimer on 2025-09-04.
How many analysts cover ENTG?
14 analysts have issued ratings for Entegris, Inc. in the past 12 months.
Is ENTG a buy or sell right now?
Based on 14 analyst ratings, ENTG has a consensus rating of Buy (2.29/5) with a +2.0% upside to the consensus target of $134.00.
What are the earnings estimates for ENTG?
Analysts estimate ENTG will report EPS of $3.41 for the period ending 2026-12-31, with revenue estimated at $3.43B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.